MAPT and Parkinson disease: DLB-AD is associated with increased age, female sex, increased APOE ε4 genotype, decreased memory, increased delusions and hallucinations, less REM-behavior sleep disorder and parkinsonism, worse language performance, faster progression, increased temporal thinning and tau pathology, and greater risk of institutionalization and mortality (2–4, 33–37).